Lipella pharmaceuticals granted fda orphan designation for oral graft-versus-host disease drug

“gvhd affects approximately 30,000 americans and oral gvhd causes significant oral pain and discomfort, making it difficult for patients to eat, drink and speak. oral gvhd is a great unmet need in cancer survivors.
LIPO Ratings Summary
LIPO Quant Ranking